Multishield DC Intramammary Suspension for Cows
Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Summary of Product characteristics
(SPC)
04-12-2015
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Neomycin Sulphate, Penethamate Hydriodide, micronised, Procaine Benzylpenicillin
Available from:
Cross Vetpharm Group Ltd
ATC code:
QJ51RC
INN (International Name):
Neomycin Sulphate, Penethamate Hydriodide, micronised, Procaine Benzylpenicillin
Pharmaceutical form:
Intramammary suspension
Prescription type:
POM-V - Prescription Only Medicine – Veterinarian
Therapeutic group:
Cattle
Therapeutic area:
Antimicrobial
Authorization status:
Authorized
Authorization date:
2013-05-02
Summary of Product characteristics
Revised: December 2013
AN: 01105/2013
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Multishield DC Intramammary Suspension for Cows
[Multishield Secado (ES)]
[Multimast Dry Cow Vet (DK)]
[Cymastin DC (CZ, HU, SK)]
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 4.5g intramammary syringe contains
Active Substances:
Neomycin
70 000 IU
(corresponding to Neomycin Sulphate
100 mg)
Penethamate
77.2 mg
(corresponding to Penethamate Hydriodide
100 mg)
Benzylpenicillin
227.2 mg
(corresponding to Procaine Benzylpenicillin
400 mg)
Excipients:
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Intramammary suspension.
A smooth, off white, oily suspension.
4. CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cows (at dry off)
4.2 INDICATIONS FOR USE
In cows at drying off:
Treatment of subclinical mastitis caused by bovine mastitis organisms sensitive to
the combination of active substances, penicillin and neomycin, and as part of
strategy for the prevention of new infections occurring during the dry period.
4.3 CONTRAINDICATIONS
Do not use in lactating cows.
Do not use in animals which are known to be hypersensitive to β-lactam
antibiotics, cephalosporin antibiotics, neomycin or other aminoglycoside antibiotics
or to iodine.
Do not use in cows with clinical mastitis.
Page 1 of 5
Revised: December 2013
AN: 01105/2013
4.4 SPECIAL WARNINGS
None.
4.5 SPECIAL PRECAUTIONS FOR USE
i)
Special precautions for use in animals
Use of the product should be based on susceptibility testing of the bacteria
isolated from the animal. If this is not possible, therapy should be based on
local (regional, farm level) epidemiol
Read the complete document
